I heard estrogen cuts Alzheimer's risk by 30 percent, or even up to 65 percent. Is that real?

Those percentages come from observational studies, where women who used hormone therapy were healthier, wealthier, and more medically engaged than women who did not, which can make hormone therapy look protective even if it is not causing the effect.

This is the same pattern of evidence that once wrongly suggested hormone therapy prevented heart attacks, before randomized trials found the opposite. A pooled analysis of observational studies does show roughly a 22 percent lower Alzheimer's risk among hormone users, but the newest and highest-quality meta-analysis, which focuses on the strongest study designs, found no protective effect at all. Any percentage like this should come with the words observational and not confirmed in randomized trials attached.

What to know about this answer

Advocates who quote large protection percentages are working from real observational numbers; the dispute is whether those numbers reflect a true drug effect or reflect the fact that healthier, more health-engaged women are the ones who use hormone therapy in the first place.

What the research shows, and which source each finding rests on

A meta-analysis of 51 observational reports found reduced Alzheimer's disease risk with hormone therapy use (RR 0.78, about a 22 percent lower risk) and reduced all-cause dementia (RR 0.81).

A [1]

The December 2025 Lancet Healthy Longevity systematic review and meta-analysis, pooling the highest-quality study designs, found no significant association between hormone therapy and dementia risk in either direction.

A [2]

Randomized trials nullified the parallel observational claim that hormone therapy prevented heart attacks, and at older ages reversed the dementia claim entirely, which is why observational protection percentages for the brain are treated with caution.

B [3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

the protection numbers are worth taking seriously and pursuing further

Avrum Bluming, Kelly Casperson, and researchers behind the observational meta-analyses

Multiple independent observational studies point the same direction, some clinicians cite figures as high as 25 to 65 percent risk reduction, and there is mechanistic imaging evidence that estrogen can lower amyloid plaque burden in the brain.

A [1]

the protection numbers are confounded and should not anchor decisions

guideline bodies and pharmacoepidemiology researchers

This is exactly the pattern that misled the field on heart disease before randomized trials corrected it, and the newest, most rigorous meta-analysis that restricts itself to the strongest designs finds no protective effect at all.

A [2]B [3]

What would settle it: A randomized prevention trial with dementia or validated biomarker endpoints and long follow-up; short of that, target-trial-emulation methods designed specifically to separate a true drug effect from healthy-user bias.

What is really going on here

Is this protection percentage from a randomized trial or an observational study?
If hormone therapy protected the brain, why did the most rigorous recent meta-analysis find nothing?

Questions for your doctor

Is dementia prevention part of the reasoning behind a hormone therapy recommendation for me, or is it symptom relief?
How confident is the evidence behind any specific percentage I've been quoted?
What is actually proven for someone in my situation, versus what is still being researched?

Questions with no answer yet

Would a properly randomized trial, rather than pooled observational data, confirm any of the specific percentages, such as 25 to 65 percent or 30 percent, that circulate for Alzheimer's risk reduction?

Studied and negative

What is known: The most current, highest-quality meta-analysis, which restricts itself to the strongest study designs, found no protective effect in either direction. No randomized trial has ever tested hormone therapy specifically for Alzheimer's prevention as a primary endpoint.

What would test it: The dedicated randomized prevention trial with dementia or biomarker endpoints described throughout this topic; short of that, target-trial-emulation methods designed to separate a true effect from healthy-user bias.

Why do different observational meta-analyses of the same general literature land on such different numbers, from no effect at all to a 22 percent or higher reduction?

Partly studied

What is known: Different meta-analyses include different combinations of studies, mix randomized and observational designs in different proportions, and use different pooling methods. One widely cited meta-analysis contains both a randomized-trials-only estimate showing harm and an observational-only estimate showing protection within the same paper.

What would test it: A pre-registered, harmonized re-analysis that separates randomized and observational evidence cleanly and reports both, rather than pooling them into a single headline number.

Sources

1.Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia.Nerattini M et al., Front Aging Neurosci 2023 · Systematic review or guideline
2.Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis.Melville M et al., Lancet Healthy Longev 2025 · Systematic review or guideline
3.Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.Shumaker SA et al. (WHIMS), JAMA 2003 · Randomised trial

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping